Trial
NCT05167370
High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
—
Condition
Solid Tumors
Intervention
Amifostine
Why stopped
The study was terminated as recommended by the DSMB due to inability to meet enrollment goals within the time frame allotted (target of 25 patients over 5 years).
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-01-25